(4aR,6R,6aR,9S,11S,11bS,12R,14R)-11b-(acetoxymethyl)-6,11-dihydroxy-4,4-dimethyl-8-methylene-7-oxotetradecahydro-6a,9-methanocyclohepta[a]naphthalen-12-yl-4-bromobutanoate

ID: ALA4780853

PubChem CID: 162663413

Max Phase: Preclinical

Molecular Formula: C26H37BrO7

Molecular Weight: 541.48

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1C(=O)[C@@]23[C@H](O)C[C@@H]4C(C)(C)CCC[C@@]4(COC(C)=O)[C@@H]2[C@@H](O)C[C@H]1[C@H]3OC(=O)CCCBr

Standard InChI:  InChI=1S/C26H37BrO7/c1-14-16-11-17(29)21-25(13-33-15(2)28)9-6-8-24(3,4)18(25)12-19(30)26(21,22(14)32)23(16)34-20(31)7-5-10-27/h16-19,21,23,29-30H,1,5-13H2,2-4H3/t16-,17+,18-,19-,21+,23-,25+,26-/m1/s1

Standard InChI Key:  RBYMOTLQGGXOGP-KYRDOMLNSA-N

Molfile:  

 
     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
   28.1436   -5.5016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7391   -4.7958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3301   -5.4990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4490   -3.5577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8729   -3.5577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4490   -4.3790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1589   -3.1449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5869   -3.1449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7391   -3.1449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5869   -2.3154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1589   -4.7958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1589   -2.3154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8729   -4.3790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0251   -4.3790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8729   -1.9068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0251   -3.5577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4490   -2.7322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1589   -3.9704    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   28.4490   -5.2044    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   31.0822   -2.8519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6653   -3.6155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7689   -1.5187    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   27.7413   -2.3236    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.7413   -1.5064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0336   -1.0978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4490   -1.0978    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.4519   -1.9054    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.0565   -4.3329    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.2947   -3.5534    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.5816   -4.7859    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.6971   -4.2552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2864   -4.9617    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.5143   -4.2576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8932   -2.7518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9208   -4.9665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7380   -4.9690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1445   -5.6779    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  7  1  0
  6  4  1  0
  7  4  1  0
  2  6  1  0
  8  5  1  0
  9  4  1  0
 10 15  1  0
 11  6  1  0
 12  7  1  0
 13  5  1  0
 14 16  1  0
 15 12  1  0
 16  9  1  0
  4 17  1  6
  7 18  1  1
  6 19  1  1
 14  2  1  0
 13 11  1  0
 10  8  1  0
 10 20  1  0
  5 21  1  1
 21 20  1  0
 10 22  1  1
 17 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 12 27  1  1
 21 28  2  0
  8 29  1  1
 13 30  1  6
 29 31  1  0
 31 32  2  0
 31 33  1  0
 20 34  2  0
 33 35  1  0
 35 36  1  0
 36 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4780853

    ---

Associated Targets(Human)

ECa-109 cell line (1254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TE-1 (337 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGC-803 (6426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 541.48Molecular Weight (Monoisotopic): 540.1723AlogP: 3.34#Rotatable Bonds: 6
Polar Surface Area: 110.13Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 2.62CX LogD: 2.62
Aromatic Rings: Heavy Atoms: 34QED Weighted: 0.30Np Likeness Score: 2.88

References

1. Huo JF,Hu TX,Dong YL,Zhao JZ,Liu XJ,Li LL,Zhang XY,Li YF,Liu HM,Ke Y,Wang C.  (2020)  Synthesis and in vitro and in vivo biological evaluation of novel derivatives of flexicaulin A as antiproliferative agents.,  208  [PMID:32883640] [10.1016/j.ejmech.2020.112789]

Source